Plastic Surgery Doctors in Hickory, NC Accepting Medicare

4 Plastic Surgery doctors found. Showing 1 - 4

Dr. Joseph Euranus Fewell Jr., M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 50 13th Ave Ne, Suite 2-b, Hickory, NC 28601 Phone: 828-322-8380    Fax: 828-328-4967

Gregory M Swank, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849    Fax: 828-325-9879

Dr. Rosiane Alfinito Roeder, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849

Dr. Steven Andrew Siciliano, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849    Fax: 828-325-9879

News Archive

Doctors' conscience has little place in the delivery of modern medical care

A doctor's conscience should not be allowed to interfere with medical care, argues an ethics expert in the British Medical Journal.

Nutrition 21: Health Canada approves chromium picolinate for sale as a natural health product

Nutrition 21, Inc., the developer and marketer of nutritional ingredients for the dietary supplement, functional food and beverage markets announced today that chromium picolinate has been officially approved for sale in Canada as a natural health product by Health Canada, the Canadian federal agency devoted to maintaining and improving the health of the nation's citizens. As a result of this approval, Nutrition 21 can now sell its Chromax® brand of chromium picolinate to Canadian manufacturers, marketers, and importers of natural health products.

TASE approves new listing of PROLOR Biotech's common stock

PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.

CHMP gives positive opinion for approval of once-daily QVA149 for treatment of COPD

Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

Schizophrenia patients likely to sustain medical injuries during non-psychiatric hospital stay

People with schizophrenia are more likely than others to sustain medical injuries during non-psychiatric hospital stays, a large national study finds.These findings confirm that medical and surgical hospitalizations are an at-risk time for this group, and a national problem, said lead study author Elizabeth Khaykin, at the Department of Mental Health at Bloomberg Johns Hopkins School of Public Health.

Read more Medical News

› Verified 3 days ago